[Etamysylate in the treatment of essential hyperlipemia].
D000328:Adult; D001557:Benzenesulfonates / Q000494:pharmacology / Q000627:therapeutic use*; D001647:Bile Acids and Salts / Q000378:metabolism; D002784:Cholesterol / Q000096:biosynthesis; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006873:Hydroquinones / Q000494:pharmacology / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000188:drug therapy*; D007408:Intestinal Absorption / Q000187:drug effects; D008074:Lipoproteins / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use
D001557:Benzenesulfonates; D001647:Bile Acids and Salts; D006873:Hydroquinones; D008074:Lipoproteins; D009539:Nicotinic Acids; D006493:Heparin; D002784:Cholesterol; D002994:Clofibrate
L'Etamsilato nella terapia delle iperlipemie essenziali.